Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation
Paul J. Egan, … , Warren S. Alexander, Ian P. Wicks
Paul J. Egan, … , Warren S. Alexander, Ian P. Wicks
Published March 15, 2003
Citation Information: J Clin Invest. 2003;111(6):915-924. https://doi.org/10.1172/JCI16156.
View: Text | PDF
Article Aging

Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation

  • Text
  • PDF
Abstract

Suppressor of cytokine signaling-1 (SOCS-1) is a negative regulator of cytokine signaling. To investigate the role of SOCS-1 in regulating inflammatory and immune responses in disease, acute inflammatory arthritis was induced in mice lacking SOCS-1. Expression of SOCS-1 protein was detected within synovial granulomas and pannus tissue of WT mice by day 7 following induction of acute arthritis. The severity of synovial inflammation and joint destruction at the peak of disease was greater in the absence of SOCS-1, although disease resolution occurred normally. There was an increased percentage of myeloid cells infiltrating the synovium in mice lacking SOCS-1, and SOCS-1 promoter activity was present in synovial macrophages, lymphocytes, and fibroblasts, but not granulocytes. The T cell response in draining LNs was also dysregulated, as popliteal LNs from mice lacking SOCS-1 contained approximately fivefold more cells at the peak of acute arthritis. These cells were hyperproliferative on exposure to antigen in vitro, and purified splenic CD4+ T cells from mice lacking SOCS-1 proliferated more strongly in response to stimulation with anti-CD3. Reporter gene expression was detected in CD4+ T cells bearing the activation markers CD25, CD44, and CD69. SOCS-1 is therefore expressed in hematopoietic and nonhematopoietic cell types in vivo and is an important regulator of acute inflammatory arthritis and of CD4+ T cell activation.

Authors

Paul J. Egan, Kate E. Lawlor, Warren S. Alexander, Ian P. Wicks

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
Expression of β-gal reporter gene activity in synovial tissue cells from...
Expression of β-gal reporter gene activity in synovial tissue cells from SOCS-1–/– IFN-γ–/– mice on day 7 of acute arthritis. Synovial tissue cells were isolated by collagenase and dispase digestion of dissected synovium and incubated with FDG for 4 hours. Cells were then stained for expression of phenotypic markers. (a) Cells were stained with CD45 and CD11b, and gated populations were analyzed by light scatter (top row) and β-gal reporter gene activity (bottom row). Cells were incubated in the presence (thin histogram) or absence (bold histogram) of FDG for 4 hours, followed by staining with phenotypic markers. (b) Cytocentrifuge preparations of CD11b+ synovial cells, sorted by flow cytometry on the basis of β-gal activity (Diff-Quik stain; magnification ×400). Results shown are representative of three independent experiments. (c) Lack of reporter gene expression in resident peritoneal macrophages. Resident peritoneal cells from naive SOCS-1–/– IFN-γ–/– mice were stained for CD11b+ expression and β-gal activity. Cells were incubated in the presence (thin histogram) or absence (bold histogram) of FDG for 4 hours. Results shown are gated for CD11b+ cells.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts